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SummAry – Clindamycin, a lincosamide antibiotic, has been under-recognized as an antimi-
crobial agent for use in dentistry. The aim of the present work was to evaluate clinical efficacy of 2% 
clindamycin gel in addition to the basic mechanical periodontal therapy. At baseline, scaling and 
root planing (SrP) was performed at all 50 subjects (control group and test group). Clindamycin gel 
was applied after SrP only in the test group. Clinical measurements including periodontal pocket 
depth (PPd), clinical attachment level (CAl), bleeding on probing (BOP) and plaque index (Pi) 
were done at baseline, and at 3 and 6 months after treatment. Compared to baseline, the PPd and 
CAl values significantly decreased in the test group (p<0.05) and were statistically lower (p<0.05) 
compared to control group. PPd reduction of 2.42 mm was obtained in the test group and could 
be generally considered as clinically significant. A PPd reduction greater than 2 mm indicated that 
clindamycin gel could be used efficiently as an adjunct to SrP. Also, between-group difference in 
BOP and Pi scores was statistically significant 6 months after treatment. in conclusion, the applica-
tion of clindamycin gel in combination with SrP enhanced the efficacy of non surgical periodontal 
therapy in reducing pocket depth and improving attachment levels in chronic periodontitis subjects 
and had additional benefits over mechanical therapy alone.
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Introduction
Chronic adult periodontitis is an inflammatory 
disease that results in destruction of the soft tissue 
and supporting bone structure of the periodontium1. 
Certain gram-negative bacteria have been implicated 
in the pathogenesis of this disease, including Porphy-
romonas gingivalis, Aggregatibacter actinomycetem comi-
tans, Prevotella intermedia and Tanerella forsythia.
in healthy adults, the resident oral microflora re-
mains relatively stable owing to a dynamic balance 
achieved by inter-bacterial and host-bacterial interac-
tions. however, variations in the microflora can be at-
tributed to the direct effect in periodontitis2.
The treatment of chronic periodontitis is focused 
on arresting destruction of the periodontal support of 
the teeth by eliminating pathogenic bacteria present 
in the inflamed pocket. it is performed by mechani-
cal scaling and root planing (SrP) and the efficacy of 
this procedure is well documented3. however, varia-
tions in the depth of periodontal pockets often result 
in variable effectiveness of SrP. Also, in many cases, 
mechanical therapy alone cannot completely elimi-
nate periodontal pathogens present in periodontal 
pockets, as they are inaccessible to the instruments. 
Complementing mechanical therapy with adjunctive 
antibacterial agents, usually in the form of irrigants, 
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systemic or local antibiotics may enhance treatment 
effects and overcome the limited efficacy of conven-
tional treatment4.
Systemic antibiotics enter periodontal tissues and 
periodontal pocket via serum and are effective in 
certain forms of periodontal disease such as aggres-
sive periodontitis. The main disadvantage of systemic 
therapy is that only a small proportion of the total drug 
dose reaches the subgingival microflora and periodon-
tal pocket. Also, the use of systemic antibiotics can 
result in bacterial resistance and very often causes un-
desirable side effects such as nausea, diarrhea, fever, ab-
dominal pain and pseudomembranous colitis that may 
be induced by long term usage. in addition, local drug 
application is a relatively simple procedure to perform 
and, moreover, patient acceptance is better as compared 
with invasive procedures such as surgical treatment4-6.
recently, a new approach using local systems con-
taining antibiotic or antiseptic drugs has been intro-
duced. The local tissue concentration of a drug can be 
enhanced by incorporating the active agent into con-
trolled release delivery systems to be placed directly 
in the periodontal pocket. Controlled release devices 
that contain tetracycline hydrochloride, doxycycline, 
minocycline, metronidazole or ofloxacin for direct 
pocket placement are commercially available in vari-
ous countries as an useful adjunct to SrP in reduction 
of probing depth4,6-8. 
Clindamycin, a lincosamide antibiotic that has 
been in use worldwide for more than 30 years, has been 
consistently effective in the treatment of infections in-
volving a wide spectrum of facultative and strictly an-
aerobic bacteria. The clinical value of clindamycin in 
a number of medical studies is well known, but it has 
been under-recognized as an antimicrobial agent for 
use in dentistry. it has been shown to be active against 
a range of gram-negative species, including Porphy-
romonas species, Prevotella species, Bacteroides fragilis 
group, Veillonella species and Fusobacterium species. in 
addition to its antimicrobial properties, clindamycin 
has anti-inflammatory activities9,10. its effectiveness 
for the treatment of periodontal disease has been in-
vestigated in a limited number of studies. 
The aim of this study was to evaluate and analyze 
clinical results and efficacy of a six-month treatment 
of periodontal disease using 2% clindamycin gel as an 
adjunctive therapy to SrP.
Materials and Methods
fifty patients, 27 male and 23 female, mean age 
47.6 years, took part in this study. The population 
group was recruited at dental Clinic in niš among 
patients with periodontitis and in good general health, 
who required periodontal treatment. Patients com-
pleted a health history questionnaire to ensure that 
they were medically qualified for participation in the 
study. A consent form was signed by each patient after 
thorough explanation of the nature of this study. The 
study was approved by the ethics Committee of the 
medical faculty, university of niš.
Patients were included in the study if they had at 
least one pocket, from 5 up to 7 mm in depth. Oral hy-
giene recommendations were reinforced at the first visit 
and each subsequent appointment. radiographic bone 
loss was recorded dichotomously (presence or absence) 
in each quadrant to confirm the diagnosis. Patients with 
any antimicrobial therapy, nonsteroidal anti-inflamma-
tory drugs, corticosteroid therapy, or patients with any 
periodontal therapy in the preceding 6 months, having 
known or suspected allergy to lincosamide antibiotics, 
smokers (current or past), or subjects using tobacco in 
any other form, alcoholics, and pregnant or lactating 
females were excluded from the study.
At baseline, all patients received SrP, but in all 
instances the subgingival instrumentation was carried 
out after recording baseline measurements. Clinical 
measurements were carried out at the deepest peri-
odontal pocket from each chosen tooth at baseline, 
and at 3 and 6 months after therapy. Clinical response 
was assessed by measuring probing depth (PPd, to 
the nearest millimeter from the free gingival margin 
to the base of the pocket), clinical attachment level 
(CAl, it was recorded to the nearest millimeters from 
the cemento-enamel junction), gingival bleeding on 
probing (BOP), and plaque index (Pi) based on a mod-
ified score of 0 to 3. BOP was evaluated using a scoring 
scheme, where 0 = no bleeding within 10 seconds after 
probing; 1 = bleeding within 10 seconds after probing; 
and 2 = bleeding on probing. Plaque scores were re-
corded as follows: 0 = no plaque present; 1 = plaque 
covering not more than 1/3 of the tooth; 2 = plaque 
covering more than 1/3, but not more than 2/3 of ex-
posed tooth surface; and 3 = plaque covering more than 
2/3 of exposed tooth surface.
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for further investigations, all patients were di-
vided into two groups. Only SrP was done in 25 
patients (control group), and the other 25 patients re-
ceived SrP plus clindamycin gel (test group). Clin-
damycin gel was supplied in a disposable applicator 
containing 10 mg clindamycin (as hydrochloride) in 
500 mg of gel. The gel was applied directly into each 
periodontal pocket of 5 to 7 mm or more with an 
endodontic syringe with a needle that had a special 
tip that was inserted to the bottom of the pocket. A 
sufficient amount of gel was used to fill each pocket 
up to the gingival margin. final follow up visits were 
3 and 6 months later. 
Statistical analysis was performed by descriptive 
and analytical statistics methodology using standard 
data processing programs mS excel and SPSS pro-
gram package version 15.0. The Student’s paired t-
test was used to compare data on PPd and CAl 
from baseline to those at 3 and 6 months for each 
treatment group and between treatment groups. 
The level of significance was set at p<0.05. Testing 
of score values for BOP and Pi was done by variant 
analysis with subsequent post-hoc test for homoge-
neous data or by Pearson χ2-test and mann-Whitney 
u test for non-homogeneous data. The level of sig-
nificance was set at p<0.05.
Results and Discussion
Periodontal disease essentially comprises of a 
group of oral infections with dental plaque as the pri-
mary etiological factor, which results in inflammatory 
lesions of the supporting tissues. removal of the cause 
of infection and its effects is the primary aim of both 
non-surgical and surgical treatment regimens. The 
major non-surgical therapeutic approach involves me-
chanical SrP. The infective nature of the disease has 
led to the widespread use of antimicrobials, especially 
systemic or local antibiotics, as an adjunct to SrP11.
Clindamycin has not been extensively used in peri-
odontal therapeutics, especially applied locally as gel. 
This clinical trial was performed to examine clinical 
efficacy of subgingivally administered 2% clindamycin 
gel in combination with SrP non-surgical treatment 
of periodontal pockets affected by chronic periodonti-
tis. during the treatment, subgingival administration 
of 2% clindamycin gel produced no systemic adverse 
effects and was generally well tolerated. Also, none of 
the patients had discoloration of teeth or other sys-
temic adverse reactions, especially pseudomembra-
nous colitis.
Table 1 and Table 2 summarize the results of clinical 
measurements. At baseline, the mean values of clini-
cal measurements revealed no significant between-
group differences. Three months after the treatment, a 
statistically significant between-group difference was 
found for PPd (p<0.05), but not for CAl, BOP and 
Pi. At 6 months after initial treatment, statistically 
significant differences between control group (SrP) 
and test group (SrP + clindamycin gel) were recorded 
for all examined clinical parameters. 
Table 1. Comparison of periodontal pocket depth and clinical attachment level mean values in test and control group 
patients at different examination intervals
examination 
interval










Baseline 6.04±0.68 5.92±0.67 0.12±0.09 p=0.635 1.58±0.32 1.62±0.29 0.04±0.29 p=0.699
At 3 months 4.76±0.65 5.45±0.57 0.69±0.48 *p=0.002 0.94±0.31 1.08±0.39 0.14±0.33 p=0.270
At 6 months 3.62±0.31 5.56±0.65 1.94±0.63 *p<0.001 0.60±0.44 0.98±0.28 0.38±0.21 *p<0.001
Total difference  
from baseline 2.42±0.44 0.36±0.29 0.98±0.36 0.64±0.42
p-valueb *p<0.001 p>0.05 *p<0.001 *p<0.05
PPd = periodontal pocket depth; CAl = clinical attachment level; Sd = standard deviation; n = number of patients; ap-value between treatment 
groups; bp-value between paired means; *statistical significance p<0.05
Acta Clin Croat,  Vol. 54,   No. 1,  2015 49
Ana Pejčić et al. Therapeutic efficacy of clindamycin gel in chronic periodontal disease
The adjunctive use of locally delivered antibiot-
ics can provide additional benefits compared to the 
conventional SrP therapy. in general, the clinical 
findings in our study with clindamycin gel are con-
sistent with those reported on the use of other locally 
delivered antibiotics12-15.
Clindamycin works primarily by binding to the 
50s ribosomal subunit of bacteria. This agent disrupts 
protein synthesis by interfering with the transpepti-
dation reaction, which thereby inhibits early chain 
elongation. in addition to the direct antibacterial ef-
fect on ribosomal units, clindamycin has a number 
of unique pharmacological features that enhance its 
clinical efficacy and reaches high concentrations in 
saliva, gingival cervical fluid and bone. The ability 
of clindamycin to reach high intracellular concentra-
tions and extended activity inside the bacterium yields 
a post-antibiotic effect by which the antimicrobial re-
mains active although serum concentration levels are 
subinhibitory10. local clindamycin therapy has been 
investigated for the treatment of periodontal disease 
in a limited number of studies16,17. in 1993, Sauvêtre et 
al. described the effect of 1% clindamycin gel on the 
microbial flora of periodontal pockets deeper than 5 
mm, but clinical data were not presented17. 
This is the first paper describing the effectiveness 
and clinical results of local clindamycin therapy as 
an adjunct to SrP in the treatment of chronic adult 
periodontitis. The reduction of all clinical parameters 
observed in this study with clindamycin gel therapy 
was generally maintained in most patients through-
out the observation period. however, in the control 
group, the noticeable changes in CAl were observed 
at 3 months after therapy and remained relatively in-
variant for up to 6 months after therapy. in the test 
group, reduction of PPd and CAl had statistically 
significant values at 3 and 6 months after treatment 
compared to baseline (Table 1). A 2-mm reduction in 
probing depth is considered as clinically relevant3,11. 
in our work, PPd reduction of 2.42 mm was obtained 
in the test group and could be generally considered as 
clinically significant. A PPd reduction greater than 
2 mm indicated that clindamycin gel could be used 
efficiently as an adjunct to SrP. Also, plaque scores 
were reduced and it was expected owing to the re-
peated instructions on oral hygiene. Bleeding scores 
were reduced owing to SrP, improvement of plaque 
scores and use of clindamycin gel.
Our findings related to clinical improvements af-
ter clindamycin gel administration are very similar to 
other studies indicating significant improvement of 
clinical measurements in patients that received SrP 
and topical doxycycline, tetracycline, azithromycin, 
minocycline or metronidazole therapy12-15,18-20.
As stated, the results of the present study showed 
that clindamycin gel was a good adjunct to SrP thera-
py at the examined depth of periodontal pocket. Also, 
we confirmed that mechanical treatment combined 
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BOP = bleeding on probing; Pi = plaque index; n = number of patients; *Pearson χ2-test; **mann-Whitney test; statistical significance for both 
tests p<0.05
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with clindamycin gel application was more effective 
and clinical improvements were predominant.
Conclusion
Within the limits of this study, we found signifi-
cant reduction of all clinical parameters in the test 
group compared to the control group. hence, it can 
be concluded that the utilization of clindamycin gel in 
combination with SrP enhances the efficacy of non-
surgical periodontal therapy in reducing pocket depth 
and improving attachment levels in chronic periodon-
titis subjects, so this antimicrobial therapy is very use-
ful as an adjunct treatment. Although plaque control 
and SrP remain important and essential in periodon-
tal therapy, topical application of clindamycin along 
with SrP had additional benefits over mechanical 
therapy alone.
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Sažetak
TerAPijSKA uČinKOViTOST KlindAmiCin gelA KAO dOdATAK BAZiČnOj TerAPiji 
KrOniČne PArOdOnTOPATije
A. Pejčić, D. Kojović, I. Minić, D. Mirković, M. Denić i M. Stojanović
Klindamicin, linkozamidni antibiotik, je u širokoj upotrebi u stomatologiji. Cilj ovoga rada je bio procijeniti kliničku 
učinkovitost 2% klindamicin gela kao dodatne terapije bazičnoj terapiji kronične parodontopatije. Bazična terapija prove-
dena je u svih 50 pacijenata (kontrolna skupina i ispitna skupina). Klindamicin gel je primijenjen nakon bazične terapije 
parodontopatije samo u ispitnoj skupini. Praćeni su sljedeći klinički parametri: dubina parodontalnog džepa (dPdZ), 
razina pripojnog epitela (nPe), indeks krvarenja (ikr), plak indeks (Pi). mjerenje indeksa provedeno je prilikom prve te-
rapije te tri i šest mjeseci nakon tretmana. dPdZ i nPe vrijednosti su bile značajno smanjene u ispitnoj skupini (p<0,05) 
i bile su statističke niže u odnosu na kontrolnu skupinu (p<0,05). Smanjenje dubine parodontalnog džepa za 2,42 mm 
zabilježeno je u ispitnoj skupini i može se smatrati klinički značajnim. Ovo smanjenje pokazuje da klindamicin gel ima 
terapijski učinak kao dodatak bazičnoj terapiji u liječenju kronične parodontopatije. Također je evidentirana statistička 
razlika između skupina u ikr i Pi šest mjeseci nakon terapije. Zaključuje se da primjena klindamicin gela u kombinaciji s 
bazičnom terapijom parodontopatije povećava učinkovitost nekirurške terapije. 
Ključne riječi: Periodontalne bolesti – terapija; Antiinfektivna sredstva, lokalna; Klindamicin
